引领霉菌毒素风险管理，百奥明®脱毒剂25年历程

29625248

For immediate release

BIOMIN Marks 25 Years of Mycofix® and Leading Mycotoxin Risk Management

引领霉菌毒素风险管理，百奥明®脱毒剂25年历程

03October 2016 – BIOMIN has announced the 25th anniversary of the launch of Mycofix®, the leading mycotoxindeactivating feedadditive, initially introduced in 1991.

2016年10月3日，是百奥明®脱毒剂推出25周年纪念日，这款引领霉菌毒素风险管理的饲料添加剂，自1991年就推向了市场。

“It’s amazing to think that some customers have been using Mycofix® for 25 years. Clients in more than 100 countries recognize Mycofix® as the most effective and innovative product of its kind. It speaks to longstanding client relationships built on science, service and speed,” remarked Erich Erber, BIOMIN Founder and President of the Supervisory Board of Erber Group, of which BIOMIN is a part.  

百奥明作为Erber集团的下属子公司，其创始人，Erber集团监理会主席 Erich Erber谈到，“难以置信有些客户已经应用百奥明®脱毒剂25年了，100多个国家的客户都认可百奥明®脱毒剂是最有效和创新的霉菌毒素处理产品。凭借科技、服务与研发速度我们与客户建立了长期稳定的合作关系。”

“Mycofix® represents decades of scientific research on mycotoxin deactivation and combines the most cutting-edge mycotoxin mitigation strategies available anywhere,” said Ursula Hofstetter, Director Competence Center Mycotoxins at BIOMIN.

百奥明霉菌毒素研发中心总监Ursula Hofstetter说，百奥明®脱毒剂融合最前沿霉菌毒素祛除策略，代表了十多年霉菌毒素脱毒科研的成果。

Science first

科学的起点

“Robust R&D efforts have always been a core component of the Mycofix® product line,” she explained. In 1988, the firm signed its first researchagreementon mycotoxindeactivation withthe University ofVeterinary Medicinein Vienna. Over time, further improvements and innovative ingredients that demobilize or degrade mycotoxins have been added.

“百奥明®脱毒剂系列产品的核心就是强大的研发”，Ursula Hofstetter解释道，1988年百奥明公司就与维也纳兽医学院签订了霉菌毒素脱毒产品研发协议，此后更多地改进与创新的将灭活或降解霉菌毒素的成分引入产品

These efforts have cumulated in the development of technologies that biotransform mycotoxins into non-toxic substances, starting with Biomin® BBSH 797 to counteract trichothecenes. FUMzyme® —an ingredient in Mycofix® that detoxifies fumonisins— represents the most recent example of such strategies.

研发成果汇集，霉菌毒素生物转化为无毒代谢物，始于Biomin® BBSH 797处理单端孢霉烯族毒素。FUMzyme®（烟曲霉毒素降解酶）是百奥明®脱毒剂中降解烟曲霉毒素的成分，代表了这些策略中最新的研发成果。

The future of mycotoxin risk management

霉菌毒素风险管理的未来

Mycofix® now addresses a much broader range of mycotoxins than ever, making it an important tool for livestock and aquaculture producers throughout the world.Biotransformation will continue to play a key role in protecting animals.

百奥明®脱毒剂研发定位于解决更多种类的霉菌毒素，成为世界各地畜禽与水产养殖者的重要工具，继续在动物保护方面发挥关键作用。

“Three decades of research and academic cooperation tells us that biotransformation is clearly the future of mycotoxin risk management. It’s targeted, irreversible and has a clear mode of action,” outlined Ms Hofstetter. “Also, it doesn’t take up much room in feed formulation. Unlike other methods, it directly addresses the root cause of health and performance issues —mycotoxins— and it’s the only way to successfully handle severe contamination levels.”

“三十年的研发与院校合作十分明确地告诉我们，生物转化是霉菌毒素风险管理的未来，生物转化具有专一性、不可逆性处理霉菌毒素特点，机理明确”。Hofstetter女士总结道，而且此方案节省配方空间。与其他方法不同，它针对引起健康与生产性能的霉菌毒素发挥作用，是成功解决重度霉菌毒素污染的唯一方法。

Proven effectiveness

有效性证明

Mycofix® contains the only EU authorized feed additives proven to adsorb harmful mycotoxins and to biotransform mycotoxins into nontoxic metabolites. Each ingredient has been evaluated in scientific and practical relevant field trials to assure effectiveness.

百奥明®脱毒剂包含了目前唯一被欧盟认证的吸附有害霉菌毒素和生物转化霉菌毒素为无毒代谢物的饲料添加剂，每种成分都经过了科学评估与相关田间试验验证来确保有效性。

____________________________________________________________

This news item is relevant to poultry, swine, ruminants and aquaculture.

本报导适用于猪禽反刍动物与水产。

For additional information on the news that is the subject of this release, contact pr@biomin.net or visit www.biomin.net.

更多相关信息，请联系pr@biomin.net 或浏览www.biomin.net

About BIOMIN

At BIOMIN we harness the power of science to support animal health and performance. By applying state-of-the-art and proprietary technology we deliver natural, sustainable and profitable solutions to the livestock industry. For over 30 years we have pioneered innovative solutions for mycotoxin risk management and gut performance. Naturally ahead.

关于百奥明

百奥明借助科技来呵护动物健康和生产性能，应用最新科技与专利技术为畜禽养殖提供自然、可持续性和盈利的解决方案。30多年来，我们已经拥有了领先和创新的霉菌毒素风险管理方案和肠道健康方案。引领自然。

Our in-house R&D program at the BIOMIN Research Center is staffed by over 100 scientific researchers and supported by eight Centers for Applied Animal Nutrition and a research network of 200 academic and research institutions globally. Our clients in the poultry, swine, cattle and aquaculture sectors are located in more than 100 countries worldwide.

百奥明研发团队拥有100多位研发人员和8个动物营养研究中心，携手全球200家科研院所通力合作。客户遍布100多个国家的猪禽牛和水产领域。